CD274 and neoplasm: Therefore, we sought to expand the existing Epic Sciences’ non-invasive liquid biopsy platform to simultaneously examine expression of PD-L1 on circulating tumor cells (CTCs) as well as quantify changes in activated immune cell populations from a single sample in patients undergoing checkpoint inhibitor therapy.